Truist Financial’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $866K | Buy |
16,304
+2,582
| +19% | +$137K | ﹤0.01% | 1651 |
|
|
2025
Q1 | $594K | Buy |
13,722
+1,705
| +14% | +$73.8K | ﹤0.01% | 1766 |
|
|
2024
Q4 | $675K | Sell |
12,017
-1,905
| -14% | -$107K | ﹤0.01% | 1722 |
|
|
2024
Q3 | $948K | Sell |
13,922
-1,907
| -12% | -$130K | ﹤0.01% | 1542 |
|
|
2024
Q2 | $669K | Sell |
15,829
-1,892
| -11% | -$79.9K | ﹤0.01% | 1800 |
|
|
2024
Q1 | $1.22M | Sell |
17,721
-1,583
| -8% | -$109K | ﹤0.01% | 1511 |
|
|
2023
Q4 | $1.43M | Buy |
19,304
+908
| +5% | +$67.2K | ﹤0.01% | 1426 |
|
|
2023
Q3 | $1.25M | Sell |
18,396
-861
| -4% | -$58.7K | ﹤0.01% | 1462 |
|
|
2023
Q2 | $1.81M | Buy |
19,257
+710
| +4% | +$66.7K | ﹤0.01% | 1300 |
|
|
2023
Q1 | $1.26M | Buy |
18,547
+442
| +2% | +$30K | ﹤0.01% | 1443 |
|
|
2022
Q4 | $896K | Sell |
18,105
-356
| -2% | -$17.6K | ﹤0.01% | 1602 |
|
|
2022
Q3 | $600K | Sell |
18,461
-617
| -3% | -$20.1K | ﹤0.01% | 1724 |
|
|
2022
Q2 | $751K | Sell |
19,078
-1,413
| -7% | -$55.6K | ﹤0.01% | 1680 |
|
|
2022
Q1 | $1.43M | Sell |
20,491
-4,482
| -18% | -$313K | ﹤0.01% | 1444 |
|
|
2021
Q4 | $1.94M | Sell |
24,973
-3,959
| -14% | -$308K | ﹤0.01% | 1302 |
|
|
2021
Q3 | $2.76M | Buy |
28,932
+1,813
| +7% | +$173K | ﹤0.01% | 1120 |
|
|
2021
Q2 | $3.37M | Buy |
27,119
+963
| +4% | +$120K | 0.01% | 1040 |
|
|
2021
Q1 | $3.45M | Buy |
26,156
+9,327
| +55% | +$1.23M | 0.01% | 995 |
|
|
2020
Q4 | $2.23M | Buy |
16,829
+1,105
| +7% | +$146K | ﹤0.01% | 1122 |
|
|
2020
Q3 | $1.6M | Buy |
15,724
+11,101
| +240% | +$1.13M | ﹤0.01% | 1156 |
|
|
2020
Q2 | $402K | Buy |
4,623
+505
| +12% | +$43.9K | ﹤0.01% | 1738 |
|
|
2020
Q1 | $239K | Sell |
4,118
-7,429
| -64% | -$431K | ﹤0.01% | 1983 |
|
|
2019
Q4 | $1.07M | Buy |
+11,547
| New | +$1.07M | ﹤0.01% | 1395 |
|